Skip to main content

Table 3 Proportions of physicians adhering to the guidelines for diabetes management for patients with cardiovascular risk

From: Adherence of physicians to evidence-based management guidelines for treating type 2 diabetes and atherosclerotic cardiovascular disease in Ajman, United Arab Emirates

Management of T2DM with cardiovascular risk

Proportion

95% CI

Prescription of SGLT2

109 (50%)

43.3–56.7

Prescription of GLP-1

47 (21.6%)

16.1–27.1

Overall adherence

122 (56%)

49.3–62.6

  1. Abbreviations: GLP-1 Glucagon-like peptide 1 agonist, SGLT2 Sodium-glucose cotransporter 2 inhibitor